December 8, 2025

PreetNama
English News

UK firm declares positive results from Covid-19 protein treatment

630

A UK-based biotech company on Monday declared positive “breakthrough” results from a clinical trial of a protein-based treatment for Covid-19, which “greatly” reduced patients requiring intensive care.

Synairgen said its SNG001 formulation uses a protein called interferon beta, which the body produces when it gets a viral infection, and is inhaled directly into the lungs of patients with coronavirus, using a nebuliser, in the hope that it will stimulate an immune response.This assessment of SNG001 in COVID-19 patients could signal a major breakthrough in the treatment of hospitalised COVID-19 patients,” said Richard Marsden, CEO of Synairgen, a respiratory drug discovery and development company which originated from research at the University of Southampton.
“We are all delighted with the trial results announced today, which showed that SNG001 greatly reduced the number of hospitalised COVID-19 patients who progressed from ‘requiring oxygen’ to ‘requiring ventilation’. It also showed that patients who received SNG001 were at least twice as likely to recover to the point where their everyday activities were not compromised through having been infected by SARS-CoV-2 (Covid-19),” he said.

In addition, SNG001 significantly reduced breathlessness, one of the main symptoms of severe Covid-19, the company said, which is now focused on working with the regulators and other key groups to progress the potential Covid-19 treatment as rapidly as possible.The trials showed that the average time coronavirus patients spent in hospital was reduced by a third, for those receiving the new drug – down from an average of nine days to six days.

The double-blind trial involved 101 volunteers who had been admitted for treatment at nine UK hospitals for Covid-19 infections. Half of the participants were given the drug, the other half got placebo – an inactive substance.

The results, published by the company under its stock market obligations, have not been published in a peer-reviewed journal as yet.

The results confirm our belief that interferon beta, a widely known drug that, by injection, has been approved for use in a number of other indications, has huge potential as an inhaled drug to be able to restore the lungs’ immune response, enhancing protection, accelerating recovery and countering the impact of SARS-CoV-2 virus,” said Professor Tom Wilkinson, Professor of Respiratory Medicine at the University of Southampton and Trial Chief Investigator.Professor Stephen Holgate, Medical Research Council Clinical Professor of Immunopharmacology at the University of Southampton and Co-Founder of Synairgen, added, “recognising that SARS-CoV-2 is known to have evolved to evade the initial antiviral response of the lung, our inhaled treatment of giving high local concentrations of interferon beta, a naturally occurring antiviral protein, restores the lung’s ability to neutralise the virus, or any mutation of the virus or co-infection with another respiratory virus such as influenza or RSV, as could be encountered in the winter if there is a resurgence of COVID-19.”Synairgen’s drug trial was the template for the Accord programme, a fast-track clinical trial scheme set up by the UK government in April to accelerate the development of new drugs for patients with Covid-19.

The team believes the drug could be even more effective at the early stages of infection.

Related posts

Seeking refuge in US, children fleeing danger are expelledWhen officers led them out of a detention facility near the US-Mexico border and onto a bus last month, the 12-year-old from Honduras and his 9-year-old sister believed they were going to a shelter so they could be reunited with their mother in the Midwest. They had been told to sign a paper they thought would tell the shelter they didn’t have the coronavirus, the boy said. The form was in English, a language he and his sister don’t speak. The only thing he recognized was the letters “Covid.” Instead, the bus drove five hours to an airport where the children were told to board a plane. “They lied to us,” he said. “They didn’t tell us we were going back to Honduras.” More than 2,000 unaccompanied children have been expelled since March under an emergency declaration enacted by the Trump administration, which has cited the coronavirus in refusing to provide them protections under federal anti-trafficking and asylum laws. Lawyers and advocates have sharply criticized the administration for using the global pandemic as a pretext to deport children to places of danger. No U.S. agents looked at the video the boy had saved on his cellphone showing a hooded man holding a rifle, saying his name, and threatening to kill him and his sister, weeks after the uncle caring for them was shot dead in June. And even though they were expelled under an emergency declaration citing the virus, they were never tested for COVID-19, the boy said. Three weeks after their uncle was killed, the children fled Honduras, crossing the U.S.-Mexico border alone. Under the normal process set out by U.S. law, they would have been referred to a government facility for youth and eventually placed with their mother. Instead, they were expelled on July 24 after three days in U.S. detention and now live in Honduras with another uncle who is looking to leave the country himself. U.S. Customs and Border Protection declined multiple requests for comment on the boy’s story, and U.S. Immigration and Customs Enforcement also declined, saying the children had been in Border Patrol custody until they boarded a deportation flight operated by ICE. Spokesmen for both agencies have refused to answer most questions about how they treat roughly 70,000 adults and children expelled under the emergency declaration issued in March. They have refused to say how they decide whether to expel children or where to detain them before expulsion, including in hotels where at least 150 unaccompanied children as young as 1 year old have been held. Much of what’s known about expulsions has come from the accounts of children like the 12-year-old boy, who recounted his experience to The Associated Press last week with a recall of details that makes him seem older.

On Punjab

Coronavirus deaths in Italy overtake China as economic damage mounts

On Punjab

Mahima Chaudhry shares throwback pic with daughter Ariana from when she was only four: ‘Times flies by so fast’

On Punjab